Cargando…
The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial
BACKGROUND: In contrast to evidence for interventions supporting victim/survivors of domestic violence and abuse (DVA), the effectiveness of perpetrator programmes for reduction of abuse is uncertain. This study aims to estimate the effectiveness and cost-effectiveness of a perpetrator programme for...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540403/ https://www.ncbi.nlm.nih.gov/pubmed/37770906 http://dx.doi.org/10.1186/s13063-023-07612-6 |
_version_ | 1785113709503315968 |
---|---|
author | Morgan, Karen Man, Mei-See Bloomer, Rachael Cochrane, Madeleine Cole, Melissa Dheensa, Sandi Eisenstadt, Nathan Feder, Gene Gaunt, Daisy M. Leach, Rwth Kandiyali, Rebecca Noble, Sian Peters, Tim J. Shirkey, Beverly A. Cramer, Helen |
author_facet | Morgan, Karen Man, Mei-See Bloomer, Rachael Cochrane, Madeleine Cole, Melissa Dheensa, Sandi Eisenstadt, Nathan Feder, Gene Gaunt, Daisy M. Leach, Rwth Kandiyali, Rebecca Noble, Sian Peters, Tim J. Shirkey, Beverly A. Cramer, Helen |
author_sort | Morgan, Karen |
collection | PubMed |
description | BACKGROUND: In contrast to evidence for interventions supporting victim/survivors of domestic violence and abuse (DVA), the effectiveness of perpetrator programmes for reduction of abuse is uncertain. This study aims to estimate the effectiveness and cost-effectiveness of a perpetrator programme for men. METHODS: Pragmatic two-group individually randomised controlled trial (RCT) with embedded process and economic evaluation. Five centres in southwest England and South Wales aim to recruit 316 (reduced from original target of 366) male domestic abuse perpetrators. These will be randomised 2:1 to a community-based domestic abuse perpetrator programme (DAPP) or usual care comparator with 12-month follow-up. Female partners/ex-partners will be invited to join the study. The intervention for men comprises 23 weekly sessions of a group programme delivered in voluntary sector domestic abuse services. The intervention for female partners/ex-partners is one-to-one support from a safety worker. Men allocated to usual care receive no intervention; however, they are free to access other services. Their partners/ex-partners will be signposted to support services. Data is collected at baseline, and 4, 8 and 12 months’ follow-up. The primary outcome is men’s self-reported abusive behaviour measured by the Abusive Behaviour Inventory (ABI-29) at 12 months. Secondary measures include physical and mental health status and resource use alongside the abuse measure ABI (ABI-R) for partners/ex-partners and criminal justice contact for men. A mixed methods process evaluation and qualitative study will explore mechanisms of effectiveness, judge fidelity to the intervention model using interviews and group observations. The economic evaluation, over a 1-year time horizon from three perspectives (health and social care, public sector and society), will employ a cost-consequences framework reporting costs alongside economic outcomes (Quality-Adjusted Life Years derived from EQ-5D-5L, SF-12 and CHU-9D, and ICECAP-A) as well as the primary and other secondary outcomes. DISCUSSION: This trial will provide evidence of the (cost)effectiveness of a DAPP. The embedded process evaluation will further insights in the experiences and contexts of participants and their journey through a perpetrator programme, and the study will seek to address the omission in other studies of economic evaluations. TRIAL REGISTRATION: ISRCTN15804282, April 1, 2019 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-023-07612-6. |
format | Online Article Text |
id | pubmed-10540403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105404032023-09-30 The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial Morgan, Karen Man, Mei-See Bloomer, Rachael Cochrane, Madeleine Cole, Melissa Dheensa, Sandi Eisenstadt, Nathan Feder, Gene Gaunt, Daisy M. Leach, Rwth Kandiyali, Rebecca Noble, Sian Peters, Tim J. Shirkey, Beverly A. Cramer, Helen Trials Study Protocol BACKGROUND: In contrast to evidence for interventions supporting victim/survivors of domestic violence and abuse (DVA), the effectiveness of perpetrator programmes for reduction of abuse is uncertain. This study aims to estimate the effectiveness and cost-effectiveness of a perpetrator programme for men. METHODS: Pragmatic two-group individually randomised controlled trial (RCT) with embedded process and economic evaluation. Five centres in southwest England and South Wales aim to recruit 316 (reduced from original target of 366) male domestic abuse perpetrators. These will be randomised 2:1 to a community-based domestic abuse perpetrator programme (DAPP) or usual care comparator with 12-month follow-up. Female partners/ex-partners will be invited to join the study. The intervention for men comprises 23 weekly sessions of a group programme delivered in voluntary sector domestic abuse services. The intervention for female partners/ex-partners is one-to-one support from a safety worker. Men allocated to usual care receive no intervention; however, they are free to access other services. Their partners/ex-partners will be signposted to support services. Data is collected at baseline, and 4, 8 and 12 months’ follow-up. The primary outcome is men’s self-reported abusive behaviour measured by the Abusive Behaviour Inventory (ABI-29) at 12 months. Secondary measures include physical and mental health status and resource use alongside the abuse measure ABI (ABI-R) for partners/ex-partners and criminal justice contact for men. A mixed methods process evaluation and qualitative study will explore mechanisms of effectiveness, judge fidelity to the intervention model using interviews and group observations. The economic evaluation, over a 1-year time horizon from three perspectives (health and social care, public sector and society), will employ a cost-consequences framework reporting costs alongside economic outcomes (Quality-Adjusted Life Years derived from EQ-5D-5L, SF-12 and CHU-9D, and ICECAP-A) as well as the primary and other secondary outcomes. DISCUSSION: This trial will provide evidence of the (cost)effectiveness of a DAPP. The embedded process evaluation will further insights in the experiences and contexts of participants and their journey through a perpetrator programme, and the study will seek to address the omission in other studies of economic evaluations. TRIAL REGISTRATION: ISRCTN15804282, April 1, 2019 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-023-07612-6. BioMed Central 2023-09-28 /pmc/articles/PMC10540403/ /pubmed/37770906 http://dx.doi.org/10.1186/s13063-023-07612-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Morgan, Karen Man, Mei-See Bloomer, Rachael Cochrane, Madeleine Cole, Melissa Dheensa, Sandi Eisenstadt, Nathan Feder, Gene Gaunt, Daisy M. Leach, Rwth Kandiyali, Rebecca Noble, Sian Peters, Tim J. Shirkey, Beverly A. Cramer, Helen The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial |
title | The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial |
title_full | The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial |
title_fullStr | The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial |
title_full_unstemmed | The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial |
title_short | The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial |
title_sort | effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540403/ https://www.ncbi.nlm.nih.gov/pubmed/37770906 http://dx.doi.org/10.1186/s13063-023-07612-6 |
work_keys_str_mv | AT morgankaren theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT manmeisee theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT bloomerrachael theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT cochranemadeleine theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT colemelissa theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT dheensasandi theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT eisenstadtnathan theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT federgene theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT gauntdaisym theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT leachrwth theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT kandiyalirebecca theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT noblesian theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT peterstimj theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT shirkeybeverlya theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT cramerhelen theeffectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT morgankaren effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT manmeisee effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT bloomerrachael effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT cochranemadeleine effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT colemelissa effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT dheensasandi effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT eisenstadtnathan effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT federgene effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT gauntdaisym effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT leachrwth effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT kandiyalirebecca effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT noblesian effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT peterstimj effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT shirkeybeverlya effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial AT cramerhelen effectivenessandcosteffectivenessofagroupdomesticabuseperpetratorprogrammeprotocolforarandomisedcontrolledtrial |